1. Home
  2. ARRY vs IMNM Comparison

ARRY vs IMNM Comparison

Compare ARRY & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARRY
  • IMNM
  • Stock Information
  • Founded
  • ARRY 1989
  • IMNM 2006
  • Country
  • ARRY United States
  • IMNM United States
  • Employees
  • ARRY N/A
  • IMNM N/A
  • Industry
  • ARRY Semiconductors
  • IMNM Medicinal Chemicals and Botanical Products
  • Sector
  • ARRY Technology
  • IMNM Health Care
  • Exchange
  • ARRY Nasdaq
  • IMNM Nasdaq
  • Market Cap
  • ARRY 785.6M
  • IMNM 748.3M
  • IPO Year
  • ARRY 2020
  • IMNM 2020
  • Fundamental
  • Price
  • ARRY $5.76
  • IMNM $8.98
  • Analyst Decision
  • ARRY Buy
  • IMNM Strong Buy
  • Analyst Count
  • ARRY 20
  • IMNM 5
  • Target Price
  • ARRY $9.47
  • IMNM $26.40
  • AVG Volume (30 Days)
  • ARRY 8.7M
  • IMNM 828.5K
  • Earning Date
  • ARRY 08-07-2025
  • IMNM 08-11-2025
  • Dividend Yield
  • ARRY N/A
  • IMNM N/A
  • EPS Growth
  • ARRY N/A
  • IMNM N/A
  • EPS
  • ARRY N/A
  • IMNM N/A
  • Revenue
  • ARRY $1,064,767,000.00
  • IMNM $10,938,000.00
  • Revenue This Year
  • ARRY $23.50
  • IMNM N/A
  • Revenue Next Year
  • ARRY $11.23
  • IMNM $310.65
  • P/E Ratio
  • ARRY N/A
  • IMNM N/A
  • Revenue Growth
  • ARRY N/A
  • IMNM N/A
  • 52 Week Low
  • ARRY $3.76
  • IMNM $5.15
  • 52 Week High
  • ARRY $12.06
  • IMNM $16.81
  • Technical
  • Relative Strength Index (RSI)
  • ARRY 42.38
  • IMNM 48.90
  • Support Level
  • ARRY $5.91
  • IMNM $8.46
  • Resistance Level
  • ARRY $6.60
  • IMNM $9.11
  • Average True Range (ATR)
  • ARRY 0.53
  • IMNM 0.49
  • MACD
  • ARRY -0.20
  • IMNM -0.10
  • Stochastic Oscillator
  • ARRY 23.25
  • IMNM 28.75

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: